-
1
المؤلفون: Dinesh Mishra, Margaret E. Gerbasi, Roy Koruth, Sameer R. Ghate, Briana Ndife, Aaron Moynahan, Daniel Stellato, P Gunda, Thomas E. Delea
المصدر: Journal of Managed Care & Specialty Pharmacy. 25:1227-1237
مصطلحات موضوعية: Adult, Budgets, Male, Proto-Oncogene Proteins B-raf, MAPK/ERK pathway, Oncology, medicine.medical_specialty, Skin Neoplasms, Pyridones, medicine.medical_treatment, Decision Making, Pharmaceutical Science, Pyrimidinones, Pharmacy, Disease-Free Survival, Drug Costs, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Oximes, Humans, Medicine, 030212 general & internal medicine, Progression-free survival, Melanoma, Aged, Trametinib, business.industry, 030503 health policy & services, Health Policy, Imidazoles, Dabrafenib, Budget impact, Middle Aged, medicine.disease, Progression-Free Survival, Clinical trial, For-Profit Insurance Plans, Models, Economic, Clinical Trials, Phase III as Topic, Chemotherapy, Adjuvant, Mutation, 0305 other medical science, business, Adjuvant, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5112ed55d08cc354d994682606656a84Test
https://doi.org/10.18553/jmcp.2019.25.11.1227Test -
2
المؤلفون: Margaret E. Gerbasi, Briana Ndife, Thomas E. Delea, Aaron Moynahan, Roy Koruth, Daniel Stellato, P Gunda, Dinesh Mishra, Sameer R. Ghate
المصدر: Journal of Medical Economics. 22:1243-1252
مصطلحات موضوعية: Proto-Oncogene Proteins B-raf, Oncology, medicine.medical_specialty, Skin Neoplasms, Pyridones, Cost effectiveness, Cost-Benefit Analysis, medicine.medical_treatment, Antineoplastic Agents, Pyrimidinones, Placebo, Disease-Free Survival, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Oximes, medicine, Humans, Melanoma, Neoplasm Staging, Trametinib, business.industry, 030503 health policy & services, Health Policy, Imidazoles, Dabrafenib, medicine.disease, Healthcare payer, BRAF V600E, Chemotherapy, Adjuvant, Lymphatic Metastasis, 030220 oncology & carcinogenesis, Drug Therapy, Combination, Quality-Adjusted Life Years, Health Expenditures, 0305 other medical science, business, Adjuvant, Models, Econometric, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::115bb8bd22b0e71a8756ed2a68b53d3aTest
https://doi.org/10.1080/13696998.2019.1635487Test -
3
المؤلفون: Vanna Chiarion-Sileni, James Larkin, Richard F. Kefford, John M. Kirkwood, Mario Mandalà, Stephanie Manson, Kohinoor Dasgupta, Victoria Atkinson, Thierry Lesimple, Marta Nyakas, Reinhard Dummer, Axel Hauschild, Andrew Haydon, Laurent Mortier, Georgina V. Long, Dirk Schadendorf, Caroline Robert, Bijoyesh Mookerjee, Mario Santinami, Ruth Plummer, Caroline Dutriaux, Jacob Schachter, Roy Koruth
المصدر: The Lancet Oncology. 20:701-710
مصطلحات موضوعية: Trametinib, education.field_of_study, medicine.medical_specialty, business.industry, Population, Medizin, Dabrafenib, Placebo, law.invention, 03 medical and health sciences, 0302 clinical medicine, Oncology, Randomized controlled trial, law, 030220 oncology & carcinogenesis, Internal medicine, Clinical endpoint, medicine, Adjuvant therapy, 030212 general & internal medicine, Progression-free survival, education, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53df44a4ff8cc03f79d33dd8da0b9b06Test
https://doi.org/10.1016/s1470-2045Test(18)30940-9 -
4
المؤلفون: Roy Koruth, Rohini Sharma, Eric Druyts, Steve Kanters, Ahmad A. Tarhini
المصدر: Journal of comparative effectiveness research. 8(16)
مصطلحات موضوعية: Oncology, Adult, Male, medicine.medical_specialty, Skin Neoplasms, Pyridones, medicine.medical_treatment, Network Meta-Analysis, Ipilimumab, Pembrolizumab, Pyrimidinones, Antibodies, Monoclonal, Humanized, Disease-Free Survival, 03 medical and health sciences, 0302 clinical medicine, Antineoplastic Agents, Immunological, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Oximes, medicine, Humans, 030212 general & internal medicine, Vemurafenib, Melanoma, Randomized Controlled Trials as Topic, Trametinib, business.industry, Health Policy, Imidazoles, Dabrafenib, Bayes Theorem, Middle Aged, medicine.disease, Combined Modality Therapy, Nivolumab, Treatment Outcome, 030220 oncology & carcinogenesis, Female, Interferons, Neoplasm Recurrence, Local, business, Adjuvant, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f129f5c06109c2061b50c615f621c4b5Test
https://pubmed.ncbi.nlm.nih.gov/31778073Test -
5
المؤلفون: Rodrigo U Villarroel, Rama Koneru, Virtudes Soriano, Jonathan S. Zager, Roy Koruth, Olivier Dereure, Maurice Perrinjaquet, Karmele Mujika, Felix Kiecker, Eva Muñoz Couselo, Lisa A. Kottschade, Yana G. Najjar, Peter Mohr, Raluca Ionescu-Ittu, Matias Chacón, Philippe Saiag, Rebecca Burne, Jochen Utikal, Florencia Cuadros, Caroline Robert, Annie Guerin
المصدر: Melanoma Management
مصطلحات موضوعية: nodal disease, medicine.medical_specialty, medicine.medical_treatment, Dermatology, Post surgery, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Chart review, melanoma, medicine, Adjuvant therapy, Stage III melanoma, In patient, 030212 general & internal medicine, Adverse effect, business.industry, Melanoma, adjuvant therapy, interferon, medicine.disease, Oncology, 030220 oncology & carcinogenesis, stage III melanoma, business, Adjuvant, Research Article, metastatic melanoma
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e5aa68063aa5a868712c65807c52b74Test
https://doi.org/10.2217/mmt-2019-0015Test